Evidence map›Paper›PMID 26056289›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Pre-TCR ligand binding impacts thymocyte development before αβTCR expression.

Robert J Mallis, Ke Bai, Haribabu Arthanari, Rebecca E Hussey, Maris Handley, Zhenhai Li, Loice Chingozha, Jonathan S Duke-Cohan, Hang Lu, Jia-Huai Wang and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Atomistic TCR-ligand interactions instruct memory T-cell differentiation.bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Food for thought: Nutrient metabolism controlling early T cell development.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Harnessing αβ T cell receptor mechanobiology to achieve the promise of immuno-oncology.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Review
  14. Article
  15. Article
  16. Notch Partners in the Long Journey of T-ALL Pathogenesis.International journal of molecular sciences · 2023
    Review
  17. Article
  18. Article
  19. Mechanosurveillance: Tiptoeing T Cells.Frontiers in immunology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Robert J MallisDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115;
Ke BaiCoulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332;
Haribabu ArthanariDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115;
Rebecca E HusseyDepartment of Medical Oncology, Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115;
Maris HandleyDepartment of Medical Oncology, Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115;
Zhenhai LiCoulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332;
Loice ChingozhaSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332;
Jonathan S Duke-CohanDepartment of Medical Oncology, Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115; Department of Medicine, Harvard Medical School, Boston, MA 02115;
Hang LuSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332;ORCID http://orcid.org/0000-0002-6881-660X
Jia-Huai WangDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115; Department of Medical Oncology, Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115; Department of Pediatrics, Harvard Medical School, Boston, MA 02115.
Cheng ZhuCoulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332;
Gerhard WagnerDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115;
Ellis L ReinherzDepartment of Medical Oncology, Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115; Department of Medicine, Harvard Medical School, Boston, MA 02115; ellis_reinherz@dfci.harvard.edu.
Harvard University · USGeorgia Institute of Technology · USDana-Farber Cancer Institute · US

Funding

T CELL SPECIFIC TRANSCRIPTION COMPLEXESP01GM047467 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WAGNER, GERHARD · 1992 to 2017
$28.6M
STRUCTURE BASIS OF IMMUNE-CELL SURFACE RECEPTOR FUNCTIONR01AI037581 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WAGNER, GERHARD · 1996 to 2021
$6.7M
Visualizing Single Integrin Conformational Changes on Living CellsR01AI044902 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI ZHU, CHENG · 2000 to 2016
$5.8M
T CELL ANTIGEN RECOGNITIONR37AI019807 · NIAID · DANA-FARBER CANCER INSTITUTE · PI REINHERZ, ELLIS L · 1999 to 2008
$4.4M
Mechanical basis of T cell receptor triggeringR01AI100643 · NIAID · VANDERBILT UNIVERSITY · PI LANG, MATTHEW J. · 2012 to 2015
$1.6M
Spatiotemporal control of reactive oxygen species in T cellsR01AI088023 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI KEMP, MELISSA LAMBETH · 2011 to 2014
$1.4M
T Cell Antigen RecognitionR01AI019807 · NIAID · DANA-FARBER CANCER INSTITUTE · PI REINHERZ, ELLIS L · 1985 to 2010
$1.3M
T Cell Antigen RecognitionR56AI019807 · NIAID · DANA-FARBER CANCER INST · PI REINHERZ, ELLIS L · 2012 to 2012
$430k
Spatiotemporal control of reactive oxygen species in T cellsR56AI088023 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI KEMP, MELISSA LAMBETH, LU, HANG · 2015 to 2015
$371k
KINETIC PROPERTIES OF SELECTINSR21AI044902 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI ZHU, CHENG · 2000 to 2000
$71k
NIAID NIH HHS R01 AI019807NIAID NIH HHS R01 AI037581NIAID NIH HHS R01 AI044902NIAID NIH HHS R01AI044902NIAID NIH HHS R01 AI088023NIAID NIH HHS R01AI088023NIAID NIH HHS R01 AI100643NIAID NIH HHS R01AI100643NIAID NIH HHS R01AI19807NIAID NIH HHS R01AI37581NIAID NIH HHS R21 AI044902NIAID NIH HHS R37 AI019807NIAID NIH HHS R56 AI019807NIAID NIH HHS R56 AI088023NIGMS NIH HHS P01GM04746NIGMS NIH HHS P01 GM047467
6 · The paper itself

Abstract

Adaptive cellular immunity requires accurate self- vs. nonself-discrimination to protect against infections and tumorous transformations while at the same time excluding autoimmunity. This vital capability is programmed in the thymus through selection of αβT-cell receptors (αβTCRs) recognizing peptides bound to MHC molecules (pMHC). Here, we show that the pre-TCR (preTCR), a pTα-β heterodimer appearing before αβTCR expression, directs a previously unappreciated initial phase of repertoire selection. Contrasting with the ligand-independent model of preTCR function, we reveal through NMR and bioforce-probe analyses that the β-subunit binds pMHC using Vβ complementarity-determining regions as well as an exposed hydrophobic Vβ patch characteristic of the preTCR. Force-regulated single bonds akin to those of αβTCRs but with more promiscuous ligand specificity trigger calcium flux. Thus, thymic development involves sequential β- and then, αβ-repertoire tuning, whereby preTCR interactions with self pMHC modulate early thymocyte expansion, with implications for β-selection, immunodominant peptide recognition, and germ line-encoded MHC interaction.

Indexed as

Amino Acid SequenceAnimalsCalciumCell DifferentiationCells, CulturedComplementarity Determining RegionsFlow CytometryHistocompatibility AntigensLigandsLymphocyte ActivationMagnetic Resonance SpectroscopyMice, Inbred C57BLMice, KnockoutModels, ImmunologicalModels, MolecularMolecular Sequence DataCalciumComplementarity Determining RegionsHistocompatibility AntigensLigandsPeptidesReceptors, Antigen, T-Cell, alpha-betabiomembrane force probeNMR spectroscopypre–T-cell receptorrepertoire selectionthymic development

Identifiers

PMID26056289
PMCPMC4500245
OpenAlexW1596309155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.